-
Tytuł:
-
Disability and its treatment in bipolar disorder patients.
-
Autorzy:
-
Huxley N; The International Consortium for Bipolar Disorder Research, Department of Psychiatry, Harvard Medical School, McLean Division of Massachusetts General Hospital, Belmont, MA, USA. nancy_ />Baldessarini RJ
-
Źródło:
-
Bipolar disorders [Bipolar Disord] 2007 Feb-Mar; Vol. 9 (1-2), pp. 183-96.
-
Typ publikacji:
-
Journal Article; Research Support, Non-U.S. Gov't; Review
-
Język:
-
English
-
Imprint Name(s):
-
Publication: Copenhagen : Wiley-Blackwell Munksgaard
Original Publication: Copenhagen, Denmark : Munksgaard, 1999-
-
MeSH Terms:
-
Disability Evaluation*
Recovery of Function*
Bipolar Disorder/*psychology
Bipolar Disorder/*therapy
Acute Disease ; Antidepressive Agents/therapeutic use ; Antipsychotic Agents/therapeutic use ; Bipolar Disorder/epidemiology ; Cognition Disorders/epidemiology ; Combined Modality Therapy ; Humans ; Prognosis ; Psychotherapy ; Severity of Illness Index
-
Liczba referencji:
-
122
-
Substance Nomenclature:
-
0 (Antidepressive Agents)
0 (Antipsychotic Agents)
-
Entry Date(s):
-
Date Created: 20070330 Date Completed: 20070509 Latest Revision: 20220408
-
Update Code:
-
20240104
-
DOI:
-
10.1111/j.1399-5618.2007.00430.x
-
PMID:
-
17391360
-
Bipolar disorders (BPD) are major, life-long psychiatric illnesses found in 2-5% of the population. Prognosis for BPD was once considered relatively favorable, but contemporary findings suggest that disability and poor outcomes are prevalent, despite major therapeutic advances. Syndromal recovery from acute episodes of mania or bipolar major depression is achieved in as many as 90% of patients given modern treatments, but full symptomatic recovery is achieved slowly, and residual symptoms of fluctuating severity and functional impact are the rule. Depressive-dysthymic-dysphoric morbidity continues in more than 30% of weeks in follow-up from initial episodes as well as later in the illness-course. As few as 1/3 of BPD patients achieve full social and occupational functional recovery to their own premorbid levels. Pharmacotherapy, though the accepted first-line treatment for BPD patients, is insufficient by itself, encouraging development of adjunctive psychological treatments and rehabilitative efforts to further limit morbidity and disability. Interpersonal, cognitive-behavioral, and psychoeducational therapies all show promise for improving symptomatic and functional outcomes. Much less is known about how these and more specific rehabilitative interventions might improve vocational functioning in BPD patients.
Zaloguj się, aby uzyskać dostęp do pełnego tekstu.